期刊文献+

高效液相色谱法测定特考韦瑞的平衡溶解度和油水分配系数 被引量:4

Determination of the equilibrium solubility of tecovirimat and its apparent oil/water partition coefficients using HPLC
原文传递
导出
摘要 目的用高效液相色谱法(HPLC)测定特考韦瑞(ST-246)在37℃水和不同pH缓冲液的平衡溶解度,以及在正辛醇-水/缓冲液系统的油水分配系数。方法采用摇瓶法测定平衡溶解度,通过药物分配平衡后在油相及水相的浓度比,计算油水分配系数。结果 ST-246在37℃水的平衡溶解度为3.35 mg/L,ST-246的表观油水分配系数为230.49(lgP=2.36),在正辛醇/pH4.0缓冲液的油水分配系数最大,为779(lgP=2.89)。结论 ST-246的水溶性较差,脂溶性不佳,其水中溶解度呈pH依赖性,增大pH可增加其溶解度。 Objective To determine the equilibrium solubility and oil/water apparent partition coefficients(lgP) of tecovirimat(ST-246) in a series of test solutions of different pH using HPLC.Methods The equilibrium solubility was determined by saturation methods,and P was calculated with the concentration ratio of the drug in oil and water phase after partition equilibrium.Results The equilibrium solubility of ST-246 is 3.35 mg/L in water at 37℃,and the oil/water lgP of ST-246 was 2.36.It has the highest partition coefficients in n-octanol/pH4.0 buffer solution system.Conclusion ST-246 has poor watersolubility and liposolubility.ST-246 is not easily soluble and a higher pH can improve its equilibrium solubility.
出处 《军事医学》 CAS CSCD 北大核心 2012年第1期49-51,55,共4页 Military Medical Sciences
基金 国家科技支撑计划资助项目(2011BAI18B01)
关键词 高效液相色谱法 特考韦瑞 平衡溶解度 油水分配系数 HPLC tecovirimat equilibrium solubility partition coefficients
  • 相关文献

参考文献2

二级参考文献13

共引文献47

同被引文献25

  • 1Smith GL, McFadden G. Smallpox: anything to declare? [J]. Nat Rev Immunol, 2002, 2(7):521-527.
  • 2Tayavanagimatt SR, Stone MACL, Weimers W,等. 多晶型物形式ST-246和制备方法[P]. 中国专利: CN 103068232 A, 2013-04-24.
  • 3Bailey TR, Rippin SR, Opsitnick E, et al. N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: identification of novel orthopoxvirus egress inhibitors [J]. J Med Chem, 2007, 50(7):1442-1444.
  • 4Duraffour S, Snoeck R, de Vos R, et al. Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures [J]. Antivir Ther, 2007, 12(8):1205-1216.
  • 5Smith SK, Olson VA, Karem KL, et al. ST-246 In vitro efficacy against smallpox and monkeypox [J]. Antimicrob Agents Chemther, 2008, 53(3):1007-1012.
  • 6Yang G, Pevear DC, Davies MH, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge [J]. J Virol, 2005, 79(20):13139-13149.
  • 7Grosenbach DW, Berhanu A, King DS, et al. Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice [J]. Proc Natl Acad Sci USA, 2010, 107(2):838-843.
  • 8Quenelle DC, Buller R, Parker S, et al. Efficacy of delayed treatment of ST-246 given orally against systemic orthopoxvirus infections in mice [J]. Antimicrob Agents Chemother, 2007, 51(2):689-695.
  • 9Higuchi T, Connors KA. Phase Solubility Techniques [M]. New York: Wiley/Interscience, 1965, 4:117-222.
  • 10Gould S, Scott RC. 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review [J]. Food Chem Toxicol, 2005, 43(10):1451-1459.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部